Amgen filed required reports with the Securities and Exchange Commission on June 16, 2026.
4 reports, 2 independent
Updated Aug 28
Gone quiet
- Reports
- 4
- Developments
- 4
- Repetition
- 25%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Amgen filed required reports with the Securities and Exchange Commission on June 16, 2026.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Amgen filed required financial reports with the SEC.1 source
- Amgen SVP sold 1,237 shares of the company stock, and Strs Ohio lowered its stake in Amgen by 7.3%, following required SEC filings.Sub-event
Amgen filed reports with the SEC.1 source
Amgen filed required reports with the SEC.1 source
Keep exploring
The entities involved
-
Amgen
American multinational biopharmaceutical company
-
Securities and Exchange Commission
government agency of the Philippines
-
SEC
Slovak company
Related events
- BeOne Medicines Ltd. listed on the Nasdaq stock exchange and made required filings with the SEC on June 11, 2026.
- Applied Materials filed reports with the SEC on June 15, 2026.
- Amgen Inc. trades on the NASDAQ stock exchange.
- Cantor Fitzgerald and other analyst firms issued ratings on Amgen stock, which is listed on the Nasdaq exchange.
- Cisco filed required reports with the SEC and traded on the Nasdaq stock exchange on June 17, 2026.